Literature DB >> 8886832

Cross reactive anti-tetanus and anti-melittin Fab fragments by phage display after tetanus toxoid immunisation.

M Vogel1, L Lai, M P Rudolf, V Curcio-Vonlanthen, S Miescher, B M Stadler.   

Abstract

Amino acid sequence homology between tetanus toxoid, a common vaccine and melittin, a bee venom allergen provided us with two antigen models for studying the production of cross reactive antibodies after immunisation. Analysis of the serum of an atopic patient recently boosted with tetanus toxoid revealed the presence of anti-melittin and anti-tetanus antibodies. From this donor a phage display Fab library was constructed five days after vaccination. Screening of this library either with melittin alone or with tetanus toxoid followed by melittin allowed the isolation of Fab fragments specific to melittin but also Fab fragments which cross react with melittin and tetanus toxoid. Amino acid analysis revealed diversity in the heavy and the light Ig chains of the melittin specific and of the cross reactive clones. Interestingly we found that the light chain recognised melittin whereas the heavy chain preferentially bound to tetanus toxoid suggesting that cross reactivity may be due to the different binding specificities of the individual Ig chains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886832

Source DB:  PubMed          Journal:  Hum Antibodies Hybridomas        ISSN: 0956-960X


  3 in total

1.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

2.  Anti-ids in allergy: timeliness of a classic concept.

Authors:  Julia Wallmann; Isabella Pali-Schöll; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2010-06       Impact factor: 4.084

3.  Mimicry of human IgE epitopes by anti-idiotypic antibodies.

Authors:  M Vogel; S Miescher; S Kuhn; A W Zürcher; M B Stadler; C Ruf; F Effenberger; F Kricek; B M Stadler
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.